ArticleBMC medicine2026
Targeting BCL-XL for degradation synergizes with gemcitabine against cholangiocarcinoma.
Qinghua Zeng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleBMC medicine2026
Qinghua Zeng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.